Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,700 | 333 | 98.7% |
| Education | $91.22 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,322 | 100 | $0 (2019) |
| GlaxoSmithKline, LLC. | $702.02 | 44 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $629.47 | 27 | $0 (2018) |
| Amgen Inc. | $316.72 | 16 | $0 (2019) |
| PFIZER INC. | $236.13 | 18 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $201.64 | 10 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $168.31 | 11 | $0 (2019) |
| Gilead Sciences, Inc. | $160.19 | 6 | $0 (2019) |
| Boston Scientific Corporation | $155.38 | 7 | $0 (2019) |
| Abbott Laboratories | $153.26 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $1,953 | 105 | AstraZeneca Pharmaceuticals LP ($590.88) |
| 2018 | $2,202 | 107 | AstraZeneca Pharmaceuticals LP ($883.00) |
| 2017 | $2,637 | 127 | AstraZeneca Pharmaceuticals LP ($848.21) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: VACCINES | ||||||
| 12/12/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: VACCINES | ||||||
| 12/10/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2019 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: VACCINES | ||||||
| 11/19/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Respiratory | ||||||
| 11/14/2019 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.87 | General |
| Category: HFCWO | ||||||
| 11/12/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: VACCINES | ||||||
| 11/04/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/01/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Respiratory | ||||||
| 10/30/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Respiratory | ||||||
| 10/28/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2019 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Education | In-kind items and services | $3.75 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Respiratory | ||||||
| 10/16/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: VACCINES | ||||||
| 10/11/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Respiratory | ||||||
| 10/11/2019 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $0.94 | General |
| Category: Respiratory | ||||||
| 10/08/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: VACCINES | ||||||
| 10/02/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Respiratory | ||||||
| 09/27/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Respiratory | ||||||
| 09/23/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 520 | 572 | $114,752 | $33,053 |
| 2022 | 16 | 1,321 | 1,562 | $288,933 | $93,303 |
| 2021 | 15 | 1,413 | 1,643 | $292,843 | $95,744 |
| 2020 | 15 | 1,417 | 1,689 | $296,825 | $88,616 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 169 | $57,460 | $14,842 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 89 | 89 | $33,642 | $13,129 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $7,050 | $1,834 | 26.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 144 | 161 | $3,220 | $1,336 | 41.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 96 | 96 | $11,520 | $790.54 | 6.9% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 15 | 15 | $900.00 | $701.85 | 78.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $960.00 | $421.08 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 219 | 331 | $112,540 | $33,243 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 191 | 191 | $72,198 | $28,648 | 39.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 83 | 83 | $7,055 | $5,686 | 80.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 78 | $18,330 | $4,851 | 26.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $6,300 | $3,076 | 48.8% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 19 | 21 | $10,920 | $2,947 | 27.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 85 | 85 | $6,800 | $2,938 | 43.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 207 | 215 | $25,800 | $2,230 | 8.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 26 | 26 | $3,250 | $1,913 | 58.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $5,775 | $1,643 | 28.4% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 36 | 36 | $2,160 | $1,637 | 75.8% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 24 | 24 | $1,440 | $1,101 | 76.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 266 | 366 | $7,320 | $1,079 | 14.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $1,920 | $803.09 | 41.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 32 | 34 | $4,250 | $777.32 | 18.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 24 | 25 | $2,875 | $731.30 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 227 | 227 | $85,793 | $35,678 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 268 | $91,120 | $28,568 | 31.4% |
About Dr. Robert Samuelson, M.D
Dr. Robert Samuelson, M.D is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497843858.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Samuelson, M.D has received a total of $6,791 in payments from pharmaceutical and medical device companies, with $1,953 received in 2019. These payments were reported across 339 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,700).
As a Medicare-enrolled provider, Samuelson has provided services to 4,671 Medicare beneficiaries, totaling 5,466 services with total Medicare billing of $310,716. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location New York, NY
- Active Since 10/11/2006
- Last Updated 05/11/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1497843858
Products in Payments
- BEVESPI AEROSPHERE (Drug) $755.20
- FASENRA (Drug) $550.02
- SYMBICORT (Drug) $379.17
- FARXIGA (Drug) $370.85
- ANORO (Drug) $343.57
- BYDUREON (Drug) $234.01
- PREVNAR - 13 (Biological) $223.06
- STIOLTO (Drug) $222.52
- Repatha (Biological) $201.46
- XARELTO (Drug) $184.97
- JARDIANCE (Drug) $167.52
- DRG IPGs (Device) $153.26
- Arikayce (Drug) $149.20
- SMARTVEST (Device) $141.82
- TRELEGY ELLIPTA (Drug) $141.09
- JANUVIA (Drug) $117.49
- BREO (Drug) $111.03
- SHINGRIX (Biological) $106.33
- TUDORZA PRESSAIR (Drug) $103.42
- Synthroid (Drug) $89.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M